@vasecredit52
беше тук преди 1 година, 4 месеци
The trial has been permitted for grant funding for 66% of the costs, which complete CA$3.seventy five million, by UK government company, the National Institute for Health and Care Research . SPL026 is an intravenous formulation of the psychedelic drug N, N-dimethyltryptamine . The research will use Functional Magnetic Resonance Imaging to […] Виж